Cong Claire Xu, EVP, Clinical Development at NovaBridge Biosciences (NBP), sold 3,282 shares at $0.79 ($3K) on 2026-08-31, disclosed to the SEC on 2026-09-01.
Open-market sale of $3k NBP by EVP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.